🇺🇸 VTRS — Viatris Inc.

Healthcare
← Volver

Precio actual

16,88 USD

Máx. histórico

76,69

4151 días

Caída desde máximo

-77,99%

Rango 52 semanas

9,43 – 18,39

Variación hoy

-0,35%

Cierre anterior

16,94

Rango de hoy

16,67 – 17,02

Volumen hoy

5.599.203

Información
Nombre completo
Viatris Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - Specialty & Generic
Empleados
30.000
PER ⓘ
—
Dividend yield
2,83% (puede no estar actualizado)
Precio objetivo analistas
18,50 USD (puede no estar actualizado)
Primera cotización
17/03/1980
Precio actualizado
hace 1 día
Sobre la empresa

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Dividendos repartidos Total últimos 12 meses: 0,4800 USD · Yield: 2,84%
Fecha de pago Importe por participación
25/03/1994 0,0119 USD
27/12/1993 0,0119 USD
24/09/1993 0,0119 USD
24/06/1993 0,0089 USD
25/03/1993 0,0089 USD
24/12/1992 0,0089 USD
24/09/1992 0,0089 USD
24/06/1992 0,0074 USD
25/03/1992 0,0074 USD
24/12/1991 0,0074 USD
24/09/1991 0,0074 USD
24/06/1991 0,0074 USD
22/03/1991 0,0074 USD
24/12/1990 0,0074 USD
24/09/1990 0,0074 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/06/2023 9,40 9,70 9,36 9,63 +2,45% 3,62% 16.920.000
12/06/2023 9,39 9,54 9,32 9,40 +0,21% 2,34% 7.293.300
09/06/2023 9,46 9,49 9,34 9,38 -1,47% 1,59% 6.546.700
08/06/2023 9,70 9,72 9,42 9,52 -1,96% 3,09% 6.159.200
07/06/2023 9,52 9,75 9,49 9,71 +2,10% 2,73% 12.644.900
06/06/2023 9,37 9,55 9,32 9,51 +1,93% 2,45% 8.214.300
05/06/2023 9,38 9,38 9,24 9,33 +0,00% 1,49% 7.840.400
02/06/2023 9,25 9,35 9,21 9,33 +1,63% 1,51% 10.189.800
01/06/2023 9,15 9,21 8,99 9,18 +0,33% 2,40% 8.523.800
31/05/2023 9,11 9,22 9,08 9,15 -0,33% 1,54% 15.248.000
30/05/2023 9,06 9,21 8,99 9,18 +0,77% 2,43% 10.331.400
26/05/2023 9,06 9,18 9,03 9,11 +0,89% 1,66% 9.488.600
25/05/2023 8,92 9,06 8,84 9,03 +0,00% 2,47% 9.529.300
24/05/2023 9,21 9,21 8,95 9,03 -2,27% 2,82% 6.534.500
23/05/2023 9,35 9,43 9,23 9,24 -2,43% 2,14% 7.322.900
22/05/2023 9,51 9,67 9,44 9,47 +1,50% 2,42% 10.476.400
19/05/2023 9,43 9,57 9,30 9,33 -0,43% 2,86% 9.588.200
18/05/2023 9,29 9,40 9,23 9,37 +0,75% 1,83% 8.050.300
17/05/2023 9,19 9,36 9,12 9,30 +1,64% 2,61% 11.848.400
16/05/2023 9,36 9,36 9,14 9,15 -2,35% 2,35% 5.863.700
15/05/2023 9,31 9,43 9,27 9,37 +0,97% 1,72% 7.036.900
12/05/2023 9,38 9,40 9,25 9,28 -0,85% 1,60% 7.601.400
11/05/2023 9,55 9,56 9,26 9,36 -2,40% 3,14% 9.556.400
10/05/2023 9,80 9,82 9,26 9,59 -1,54% 5,71% 16.503.300
09/05/2023 9,74 9,85 9,63 9,74 -0,81% 2,26% 12.013.300
08/05/2023 9,60 10,09 9,36 9,82 +5,82% 7,60% 24.026.400
05/05/2023 9,10 9,30 9,08 9,28 +2,88% 2,42% 14.022.000
04/05/2023 9,12 9,14 8,95 9,02 -1,31% 2,08% 9.198.100
03/05/2023 9,16 9,25 9,10 9,14 +0,22% 1,64% 10.348.000
02/05/2023 9,34 9,36 8,93 9,12 -2,56% 4,60% 9.547.100